In pancreatic cancer (PDAC) progression, the various isoforms of this multifunctional onco-protein sustain EMT by inducing the transcriptional activation of the mesenchymal biomarker N-cadherin, resulting in the promotion of mesenchymal cell characteristics, proliferation, migration, invasion, and colony formation [23]. Here, CDH2 is linked to pancreatic neoplasm.